Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
bioMerieux stock logo
BMXMF
bioMerieux
$142.45
$136.47
$96.54
$143.47
$16.86B0.743 shsN/A
Deutsche Wohnen AG stock logo
DWHHF
Deutsche Wohnen
$24.28
$24.28
$18.24
$28.65
N/A0.862 shsN/A
Ferrovial SE stock logo
FRRVY
Ferrovial
$31.00
+1.2%
$31.00
$21.90
$33.57
$22.55B0.997,322 shs39,400 shs
Omron Corp. stock logo
OMRNY
Omron
$26.86
+1.9%
$26.78
$24.16
$47.75
$5.54B1.0447,012 shs53,331 shs
Sino Biopharmaceutical stock logo
SBMFF
Sino Biopharmaceutical
$0.71
$0.60
$0.34
$0.77
$13.37B0.62,441 shsN/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
bioMerieux stock logo
BMXMF
bioMerieux
0.00%0.00%-0.71%+15.21%+43.27%
Deutsche Wohnen AG stock logo
DWHHF
Deutsche Wohnen
0.00%0.00%0.00%0.00%+33.10%
Ferrovial SE stock logo
FRRVY
Ferrovial
0.00%0.00%0.00%0.00%0.00%
Omron Corp. stock logo
OMRNY
Omron
+1.86%+4.49%+0.70%-3.95%-26.03%
Sino Biopharmaceutical stock logo
SBMFF
Sino Biopharmaceutical
0.00%+4.29%+12.97%+56.76%+121.23%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
bioMerieux stock logo
BMXMF
bioMerieux
N/AN/AN/AN/AN/AN/AN/AN/A
Deutsche Wohnen AG stock logo
DWHHF
Deutsche Wohnen
N/AN/AN/AN/AN/AN/AN/AN/A
Ferrovial SE stock logo
FRRVY
Ferrovial
N/AN/AN/AN/AN/AN/AN/AN/A
Omron Corp. stock logo
OMRNY
Omron
1.6111 of 5 stars
0.03.01.70.00.90.02.5
Sino Biopharmaceutical stock logo
SBMFF
Sino Biopharmaceutical
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
bioMerieux stock logo
BMXMF
bioMerieux
3.00
BuyN/AN/A
Deutsche Wohnen AG stock logo
DWHHF
Deutsche Wohnen
0.00
N/AN/AN/A
Ferrovial SE stock logo
FRRVY
Ferrovial
0.00
N/AN/AN/A
Omron Corp. stock logo
OMRNY
Omron
0.00
N/AN/AN/A
Sino Biopharmaceutical stock logo
SBMFF
Sino Biopharmaceutical
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest OMRNY, SBMFF, DWHHF, FRRVY, and BMXMF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/7/2025
bioMerieux stock logo
BMXMF
bioMerieux
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeModerate Buy ➝ Hold
(Data available from 7/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
bioMerieux stock logo
BMXMF
bioMerieux
$4.31B3.91$4.48 per share31.79$38.50 per share3.70
Deutsche Wohnen AG stock logo
DWHHF
Deutsche Wohnen
$1.49BN/AN/AN/A$37.85 per shareN/A
Ferrovial SE stock logo
FRRVY
Ferrovial
$7.96B2.83$0.31 per share99.44$9.15 per share3.39
Omron Corp. stock logo
OMRNY
Omron
$5.26B1.05$1.59 per share16.91$29.90 per share0.90
Sino Biopharmaceutical stock logo
SBMFF
Sino Biopharmaceutical
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
bioMerieux stock logo
BMXMF
bioMerieux
$467.68MN/A0.00N/AN/AN/AN/A9/4/2025 (Estimated)
Deutsche Wohnen AG stock logo
DWHHF
Deutsche Wohnen
-$638.98MN/A0.00N/AN/AN/AN/A8/8/2025 (Estimated)
Ferrovial SE stock logo
FRRVY
Ferrovial
$187.57MN/A0.00N/AN/AN/AN/AN/A
Omron Corp. stock logo
OMRNY
Omron
$107.39M$0.5647.9617.00N/A2.07%1.75%1.22%8/1/2025 (Estimated)
Sino Biopharmaceutical stock logo
SBMFF
Sino Biopharmaceutical
N/AN/A0.00N/AN/AN/AN/A8/11/2025 (Estimated)

Latest OMRNY, SBMFF, DWHHF, FRRVY, and BMXMF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q4 2025
Omron Corp. stock logo
OMRNY
Omron
$0.4052$0.30-$0.1052$0.30$1.48 billion$1.53 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
bioMerieux stock logo
BMXMF
bioMerieux
N/AN/AN/AN/AN/A
Deutsche Wohnen AG stock logo
DWHHF
Deutsche Wohnen
N/AN/AN/AN/AN/A
Ferrovial SE stock logo
FRRVY
Ferrovial
N/AN/AN/AN/AN/A
Omron Corp. stock logo
OMRNY
Omron
$0.612.27%N/A108.93%N/A
Sino Biopharmaceutical stock logo
SBMFF
Sino Biopharmaceutical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
bioMerieux stock logo
BMXMF
bioMerieux
0.08
2.20
1.29
Deutsche Wohnen AG stock logo
DWHHF
Deutsche Wohnen
N/A
6.45
6.45
Ferrovial SE stock logo
FRRVY
Ferrovial
N/AN/AN/A
Omron Corp. stock logo
OMRNY
Omron
0.13
2.31
1.57
Sino Biopharmaceutical stock logo
SBMFF
Sino Biopharmaceutical
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
bioMerieux stock logo
BMXMF
bioMerieux
N/A
Deutsche Wohnen AG stock logo
DWHHF
Deutsche Wohnen
N/A
Ferrovial SE stock logo
FRRVY
Ferrovial
N/A
Omron Corp. stock logo
OMRNY
Omron
1.09%
Sino Biopharmaceutical stock logo
SBMFF
Sino Biopharmaceutical
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
bioMerieux stock logo
BMXMF
bioMerieux
14,600118.36 millionN/ANot Optionable
Deutsche Wohnen AG stock logo
DWHHF
Deutsche Wohnen
4,942N/AN/ANot Optionable
Ferrovial SE stock logo
FRRVY
Ferrovial
18,680727.44 millionN/ANot Optionable
Omron Corp. stock logo
OMRNY
Omron
28,450206.24 millionN/ANot Optionable
Sino Biopharmaceutical stock logo
SBMFF
Sino Biopharmaceutical
25,80618.79 billionN/ANot Optionable

Recent News About These Companies

Sino Biopharmaceutical Ltd (1177) - Investing.com UK
SBMFF Sino Biopharmaceutical Limited
U.S. FDA Approves China-Produced Cancer Drug

New MarketBeat Followers Over Time

Media Sentiment Over Time

bioMerieux stock logo

bioMerieux OTCMKTS:BMXMF

$142.45 0.00 (0.00%)
As of 07/11/2025

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries. It also provides a suite of software products and services that collect, analyze, and merge various sources of data to make decisions under the BIOMÉRIEUX VISION SUITE name; designs, manufactures, and maintains instruments and software; and designs and manufactures reagents for in vitro diagnostic tests. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

Deutsche Wohnen stock logo

Deutsche Wohnen OTCMKTS:DWHHF

$24.28 0.00 (0.00%)
As of 07/11/2025

Deutsche Wohnen SE develops and manages residential properties in Germany. The company operates through Rental, Value-add, Recurring Sales, Development, and Care segment. The Rental segment offers value-enhancing management to residential real estate portfolio. The Value- add segment engages in the core business of letting. This segment also includes multimedia services and the supply of energy. The Recurring Sales segment includes sales of individual condominiums and single-family homes. The Development segment includes project development to create new living space. The care segment includes all activities related to the management of care facilities and the leasing of care properties. Deutsche Wohnen SE was founded in 1924 and is headquartered in Berlin, Germany. Deutsche Wohnen SE operates as a subsidiary of Vonovia SE.

Ferrovial stock logo

Ferrovial OTCMKTS:FRRVY

$31.00 +0.37 (+1.21%)
As of 08/3/2023

Ferrovial SE, together with its subsidiaries, develops transport infrastructure, mobility solutions, civil works, and buildings projects in Spain and internationally. The company designs and builds various public and private works; and develops, finances, and operates toll roads. Its construction activities include highways, tunnels, bridges, and airports; designs, constructs, operates and maintains potable water treatment plants, urban and industrial waste water treatment plants, and desalination plants. In addition, the company manufactures and markets asphalt and bitumen products; develops, operates, and manages airports; and promotes, constructs, and operates energy generation and transmission infrastructures. Further, it provides mobility services, include ZITY, an electric carsharing service application; invests in electric vehicle sector, including cars and associated charging infrastructures; and sells, rents, and maintains hydraulic equipment, jacks, and floating caisson equipment. The company was founded in 1952 and is based in Madrid, Spain.

Omron stock logo

Omron OTCMKTS:OMRNY

$26.86 +0.49 (+1.86%)
As of 07/11/2025 03:56 PM Eastern

OMRON Corporation engages in industrial automation, device and module solutions, social systems, and healthcare businesses worldwide. The Industrial Automation Business offers sensors, switches, safety and control components, relays, motion and drives, robotics, energy conservation, power supplies, and automation system products. It also offers environmental mobility, digital devices, food and commodity, logistic and warehouse automation, medical, robotic, panel, vision, software, and traceability related solutions. The Social Systems, Solutions and Service Business provides energy, public transport, traffic safety, network protection, payment, infrastructure monitoring, management service, and DX solutions, as well as offers remote surveillance/monitoring, automation/robotics, software development, engineering/maintenance, and other services. The Healthcare Business provides cardiovascular, respiratory care, pain management, remote patient monitoring, and other solutions. The Device and Module Solutions Business offers relays, switches, connectors, and sensors. OMRON Corporation was founded in 1933 and is headquartered in Kyoto, Japan.

Sino Biopharmaceutical stock logo

Sino Biopharmaceutical OTCMKTS:SBMFF

$0.71 0.00 (0.00%)
As of 07/11/2025

Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines, including anlotinib hydrochloride capsules under Focus V brand, penpulimab injection under Annike brand, efbemalenograstin alfa injection under Yilishu brand, pomalidomide capsules under Anyue brand, bevacizumab injection under Anbeisi brand, rituximab injection under Delituo brand, and trastuzumab for injection under Saituo brand; liver disease medications, such as magnesium isoglycyrrhizinate injection under Tianqing Ganmei brand and entecavir dispersible tablets under Runzhong brand; and respiratory system medicines comprising budesonide suspension for inhalation under Tianqing suchang brand and colistimethate sodium for injection under Tianyun brand. It also provides surgery/analgesia medicines, including flurbiprofen cataplasms under the brand Zepolas, limaprost tablets under the brand Kailitong, and recombinant human coagulation factor VIII for injection under the brand Anhengji; cardio-cerebral vascular medicines, such as irbesartan and hydrochlorothiazide tablets under the brand Yilunping and beraprost sodium tablets under the brand Kaina; and biosimilar medicines comprising adalimumab solution for injection under the brand Taibowei. In addition, the company develops oncology drugs, include benmelstobart, D-1553, TQ-B3139, and TQ-B3101; liver disease drugs, such as Lanifibranor and TQA2225/AP025; respiratory system drugs comprising TDI01, TQC2731, TCR1672, TQC3721, and TQH2722; and surgery/analgesia drugs, including PL-5, an antimicrobial peptide. Further, it is involved in the long-term investments; and healthcare and hospital business. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.